Clinical Trial Update: The Efficacy of Pyridostigmine Therapy After Transurethral Resection of Prostate in Cases with Underactive Urinary Bladder. [Phase 4]

View source ↗

Summary

Phase 4 trial assessing whether pyridostigmine improves outcomes after transurethral resection of the prostate in men with underactive bladder; the study has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia
• Underactive Bladder

Drugs mentioned

• Pyridostigmine (pyridostigmine)

Snippet

Sponsor: Menoufia University | Conditions: Underactive Bladder, TURP(transurethral Resection of Prostate) | Phase 4 | Status: COMPLETED